The PKG™ system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of Parkinson's medication.
27 February 2017Read More
GKC's President and CEO, Timothy Still, has been invited to present at the 29th Annual ROTH conference to be held in California, USA in March 2017.
The conference brings together over 4000 attendees …
31 January 2017Read More
Global Kinetics Corporation is pleased to be working with neurologist and Parkinson's UK-funded researcher. Dr Alastair Noyce from the Institute of Neurology, University College London, to help spot e…
20 January 2017Read More
Global Kinetics Corporation would like to congratulate it's partner uMotif on their publication in the peer-reviewed journal Nature Parkinson’s Journal.
The multi-centre study showed that the uMotif …